CAS: 71636-61-8 - (+/-)-6-chloro-pb hydrobromide
Fórmula:C16H17BrClNO2
InChI:InChI=1/C16H16ClNO2.BrH/c17-15-11-6-7-18-9-13(10-4-2-1-3-5-10)12(11)8-14(19)16(15)20;/h1-5,8,13,18-20H,6-7,9H2;1H
- Sinónimos:
- Sk&F 81297
- 6-Chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol
- Skf-81297
- 1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-phenyl-
- 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
- 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol hydrobromide (1:1)
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
(±)-6-Chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[D]azepine-7,8-diol hydrobromide REF: 3D-WCA63661CAS: 71636-61-8 | Min. 95% | 138,00 €~647,00 € | Mar 21 Ene 25 | |
SKF 81297 REF: TM-T81152CAS: 71636-61-8 | 98% | A consultar | Mar 11 Feb 25 | |
(±)-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide REF: 10-F227442CAS: 71636-61-8 | >98% | - - - | Producto descatalogado |
(±)-6-Chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[D]azepine-7,8-diol hydrobromide
CAS:71636-61-8
(±)-6-Chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[D]azepine-7,8-diol hydrobromide is a dopaminergic antagonist. It binds to the d2 receptor and inhibits synaptic …
Fórmula:
C16H17BrClNO2
Pureza:
Min. 95%
Peso molecular:
370.7 g/mol
Ref: 3D-WCA63661
1mg | 138,00 € | ||
2mg | 194,00 € | ||
5mg | 310,00 € | ||
10mg | 436,00 € | ||
25mg | 647,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
SKF 81297
CAS:71636-61-8
SKF 81297 is a selective and potent agonist for the dopamine D1 receptor [1].
Fórmula:
C16H16ClNO2
Pureza:
98%
Forma y color:
Liquid
Peso molecular:
289.76
Ref: TM-T81152
5mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 11 de Febrero de 2025
(±)-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide
CAS:71636-61-8
Pureza:
>98%
Peso molecular:
370.67
Ref: 10-F227442
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información |